Author(s): Chang MC, Wong JM, Chang YT
Abstract Share this page
Abstract Pancreatic cancer is a serious growing health issue in developed countries. For patients diagnosed with pancreatic cancer, the five year survival rate is below 5\%. One major important reason leads to the poor survival rate is lack of early detection of pancreatic cancer. Over 80\% of the patients are diagnosed in advanced disease stages. Screening for pancreatic cancer is a desirable option for high risk individuals to allow early detection and treatment of curable pancreatic neoplasms at a pre-invasive stage. This article highlights the need, endpoint, population, method, diagnostic yield, and the problems of current screening programs.
This article was published in World J Gastroenterol
and referenced in Journal of Cell Science & Therapy